financetom
Business
financetom
/
Business
/
Major US Pharmacy Benefit Managers Inflated Drug Prices for Over $7.3 Billion Gain, FTC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Major US Pharmacy Benefit Managers Inflated Drug Prices for Over $7.3 Billion Gain, FTC Says
Jan 14, 2025 9:08 AM

11:59 AM EST, 01/14/2025 (MT Newswires) -- UnitedHealth Group's ( UNH ) OptumRx, CVS Health's ( CVS ) Caremark Rx and Cigna's ( CI ) Express Scripts marked up a number of specialty generic drugs at their affiliated pharmacies by hundreds or thousands of percent, the US Federal Trade Commission said Tuesday.

The practice allowed the three pharmacy benefit managers and their affiliated specialty pharmacies to generate revenue of more than $7.3 billion from dispensing drugs in excess of their projected acquisition costs from 2017 to 2022, the FTC said.

UnitedHealth ( UNH ), CVS and Cigna ( CI ) didn't immediately respond to MT Newswires' requests for comment.

Price: 537.34, Change: -3.80, Percent Change: -0.70

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved